As discussed here, the percent change from baseline used to define “response” in solid tumor oncology trials is clinically inappropriate and unintuitive to many of us physicians. A tumor that grows from 1 cm to 2 cm in max diameter is very different than one that grows from 5 cm to 10 cm. Our clinical response to the latter will often be very different than the former even though both correspond to “100% increase from baseline”.
3 Likes